相似文献
1
Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232.
2
Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096.
3
ECGs before stimulants in children.
Med Lett Drugs Ther. 2008 Jul 28;50(1291):60.
4
Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.
Pediatrics. 2012 Feb;129(2):222-30. doi: 10.1542/peds.2011-1574. Epub 2012 Jan 16.
5
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.
Can J Cardiol. 2009 Nov;25(11):625-30. doi: 10.1016/s0828-282x(09)70157-6.
6
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573.
7
Stimulants for kids with ADHD--how to proceed safely.
J Fam Pract. 2014 Feb;63(2):E1-5.
8
Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants.
J Child Adolesc Psychopharmacol. 2012 Oct;22(5):375-84. doi: 10.1089/cap.2011.0141.
9
Stimulants and sudden death: what is a physician to do?
Pediatrics. 2006 Sep;118(3):1215-9. doi: 10.1542/peds.2006-0942.
10
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. Epub 2008 Apr 21.
引用本文的文献
1
An Evaluation of Whether Routine QTc Interval Screening Is Necessary Prior to Starting ADHD Medications: Experience from a Large Retrospective Study.
Pediatr Rep. 2024 Dec 11;16(4):1161-1168. doi: 10.3390/pediatric16040098.
2
Sudden unexplained cardiac arrest in apparently healthy children: a single-center experience.
Pediatr Cardiol. 2013 Mar;34(3):639-45. doi: 10.1007/s00246-012-0516-0. Epub 2012 Oct 4.
3
How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD.
ISRN Pharmacol. 2012;2012:170935. doi: 10.5402/2012/170935. Epub 2012 Mar 5.
4
Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.
Pediatrics. 2012 Feb;129(2):222-30. doi: 10.1542/peds.2011-1574. Epub 2012 Jan 16.
5
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.
Ann Intern Med. 2010 Mar 2;152(5):276-86. doi: 10.7326/0003-4819-152-5-201003020-00005.
本文引用的文献
1
Reframing evidence synthesis as rhetorical action in the policy making drama.
Healthc Policy. 2006 Jan;1(2):34-42.
2
Recently trained general pediatricians: perspectives on residency training and scope of practice.
Pediatrics. 2009 Jan;123 Suppl 1:S38-43. doi: 10.1542/peds.2008-1578J.
3
Using decision analysis to better evaluate pediatric clinical guidelines.
Health Aff (Millwood). 2008 Sep-Oct;27(5):1467-75. doi: 10.1377/hlthaff.27.5.1467.
4
American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.
J Dev Behav Pediatr. 2008 Aug;29(4):335. doi: 10.1097/DBP.0b013e31318185dc14.
5
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573.
6
Group's advice on cardiac testing for children with ADHD draws criticism.
JAMA. 2008 Jun 18;299(23):2735. doi: 10.1001/jama.299.23.2735.
7
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. Epub 2008 Apr 21.
8
Pediatric workforce: a look at pediatric cardiology data from the American Board of Pediatrics.
J Pediatr. 2006 Mar;148(3):384-385. doi: 10.1016/j.jpeds.2006.01.053.
9
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies.
Psychol Med. 2006 Feb;36(2):159-65. doi: 10.1017/S003329170500471X.
10
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.
Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
Zotero 插件